Literature DB >> 12644025

Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease.

Ronnie Fass1.   

Abstract

Symptomatic, or nonerosive, gastroesophageal reflux disease (GERD) is the most common presentation of GERD. Patients with symptomatic GERD more frequently are younger, female, weigh less, and are less likely to have a hiatal hernia compared with patients who have erosive GERD. Physiologically, these patients demonstrate minimal esophageal motor abnormalities. However, despite a common clinical presentation and similar endoscopic findings, symptomatic GERD is comprised of a heterogeneous group of patients. There are several identifiable subgroups differentiated by the underlying mechanisms causing their heartburn symptoms, distinctions that may explain the relatively low symptom response rate to potent antireflux treatment observed among these patients as compared with those with erosive esophagitis.

Entities:  

Mesh:

Year:  2003        PMID: 12644025     DOI: 10.1016/s0002-9270(03)00009-1

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  37 in total

1.  Validity of endoscopic classification of nonerosive reflux disease.

Authors:  Takashi Joh; Hiroto Miwa; Kazuhide Higuchi; Tomohiko Shimatani; Noriaki Manabe; Kyoichi Adachi; Tsuneya Wada; Makoto Sasaki; Yasuhiro Fujiwara; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces.

Authors:  Ricard Farré; Rita De Vos; Karel Geboes; Kristine Verbecke; Pieter Vanden Berghe; Inge Depoortere; Kathleen Blondeau; Jan Tack; Daniel Sifrim
Journal:  Gut       Date:  2007-02-01       Impact factor: 23.059

3.  Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.

Authors:  Kiyoshi Ashida; Yoshikazu Kinoshita; Michio Hongo
Journal:  Dig Dis Sci       Date:  2011-02-08       Impact factor: 3.199

4.  Maintenance therapy of gastroesophageal reflux disease.

Authors:  Akihito Nagahara; Mariko Hojo; Daisuke Asaoka; Sumio Watanabe
Journal:  Clin J Gastroenterol       Date:  2010-02-19

5.  The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications.

Authors:  Jimmy M Bautista; Wai-Man Wong; Gloria Pulliam; Romeo F Esquivel; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 6.  Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Authors:  Katsuhiko Iwakiri; Yoshikazu Kinoshita; Yasuki Habu; Tadayuki Oshima; Noriaki Manabe; Yasuhiro Fujiwara; Akihito Nagahara; Osamu Kawamura; Ryuichi Iwakiri; Soji Ozawa; Kiyoshi Ashida; Shuichi Ohara; Hideyuki Kashiwagi; Kyoichi Adachi; Kazuhide Higuchi; Hiroto Miwa; Kazuma Fujimoto; Motoyasu Kusano; Yoshio Hoshihara; Tatsuyuki Kawano; Ken Haruma; Michio Hongo; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-06-21       Impact factor: 7.527

7.  Therapeutic effects of laparoscopic fundoplication for nonerosive gastroesophageal reflux disease.

Authors:  Nobuo Omura; Hideyuki Kashiwagi; Fumiaki Yano; Kazuto Tsuboi; Yoshio Ishibashi; Naruo Kawasaki; Yutaka Suzuki; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

8.  Relationship of the frequency scale for symptoms of gastroesophageal reflux disease with endoscopic findings of cardiac sphincter morphology.

Authors:  Kazuto Tsuboi; Nobuo Omura; Fumiaki Yano; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

9.  High expression of calcitonin gene-related peptide and substance P in esophageal mucosa of patients with non-erosive reflux disease.

Authors:  Xiaorong Xu; Zhaoshen Li; Duowu Zou; Min Yang; Zhanju Liu; Xingpeng Wang
Journal:  Dig Dis Sci       Date:  2012-09-09       Impact factor: 3.199

Review 10.  Nonerosive reflux disease: a pathophysiologic perspective.

Authors:  John D Long; Roy C Orlando
Journal:  Curr Gastroenterol Rep       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.